NAYA Biosciences spins off cancer drug business 6 months after INVO merger
Fecha de publicación:
15/04/2025
Fuente:FierceBiotech
Having picked up a pipeline of oncology drugs as part of a merger last year, NAYA Biosciences is reverting back to its original focus of fertility and spinning off the cancer business.